Global brokerage JP Morgan believes that both Swiggy and Zomato are available at attractive prices for taking positions in ...

Buoyed by the recent launch of Stelo and further upcoming CGM launches, Dexcom is anticipating a 14% growth in 2025 over 2024 ...

JPMorgan’s net income soared 50% to more than $14 billion in the fourth quarter as the bank’s profit and revenue easily beat ...

Fintel reports that on January 10, 2025, JP Morgan upgraded their outlook for Mohawk Industries (NYSE:MHK) from Neutral to ...

Fintel reports that on January 14, 2025, JP Morgan upgraded their outlook for CommScope Holding (NasdaqGS:COMM) from Underweight to Neutral. Analyst Price Forecast Suggests 16.38% Downside As of ...

Fresh off a record year for profit and revenue, JPMorgan is facing questions over what CFO Jeremy Barnum admitted was excess ...

Archer Aviation (NYSE: ACHR) stock saw strong bullish momentum across 2024's trading. The company's share price closed out ...

JPMorgan, Wells Fargo, Goldman Sachs and Citi kicked off earnings season on Wednesday with their December-quarter results.

Analysis of JPMorgan Chase and Goldman Sachs Q4 2024 earnings forecasts, including key metrics, analyst expectations and ...

JPMorgan shares jumped on the bank's final financial results of 2024, climbing 2.6% before the bell. Wells Fargo’s net income ...

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) 43rd Annual J.P. Morgan Healthcare Conference January 13, 2025 10:30 AM ETCompany ParticipantsDr.

Citigroup climbed 5.7 per cent and Goldman Sachs gained 5.4 per cent after both banks beat Wall Street profit forecasts. Goldman said its global banking and markets business generated nearly US$35 ...